During this period, the GLP-1 mediated slowing of gastric emptying becomes less noticeable as your digestive system adjusts
However, there are no known data on the effect of GIP on airway inflammation as of yet
10.2337/dc12-2006
Medicare Part D launched the GLP-1 Bridge program on July 1, 2026, covering Wegovy (injection and tablet), Zepbound (KwikPen only), and Foundayo for weight management at $50/month through December 31, 2027
Most once-weekly GLP-1 medications have a half-life of approximately seven days
Healthcare Systems and Providers: As referenced above, health systems will need to understand how a reduction in certain diseases and a healthier population will impact the demand for different services, and how they need to adapt their service configuration to meet evolving population needs